There are currently no clinical studies linking tirzepatide to vivid dreams, and they are not listed as a recognised adverse effect in the prescribing information
Key Implication: Patent expiry allows domestic players to launch lower-priced generics, which could meaningfully expand access in India where GLP-1 drugs remain expensive
However, individual responses vary significantly, and some patients respond better to semaglutide than tirzepatide
Jacques A, Chaaya N, Beecher K, Ali A, Belmer A, Bartlett S
If you have any more questions, please call our Customer Care Center at 1-800-727-6500
weight reduction also supported that improvements were more pronounced for those with higher BMI and more weight loss (Supplementary Table 9)